跳至主要内容
临床试验/NCT03631602
NCT03631602Unknown2 期

Posaconazole Oral Suspension and Itraconazole Oral Solution in Preventing Invasive Fungal Disease (IFD) in Patients With Hematopoietic Stem Cell Transplantation

Fujian Medical University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2017年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
120
试验地点
1
主要终点
Incidence of breakthrough IFD

研究概览

简要总结

Invasive Fungal Disease (IFD) after haematopoietic stem cell transplantation (HSCT) remain a clinical challenge.The studay aims to compare the efficacy and safety of posaconazole oral suspension vs itraconazole oral solution in preventing IFD post-HSCT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed written informed consent Aged ≥13 years Patients undergoing hematopoietic stem cell transplantation. Cardiac: Left ventricular ejection fraction ≥ 50% Adequate renal and hepatic function Performance status: Karnofsky ≥ 70%

排除标准

  • Pregnant or lactating females Any co-morbidity precluding the administration ofposaconazole or itraconazole

研究组 & 干预措施

Arm 1

Experimental

posaconazole oral suspension

干预措施: antifungal prophylaxis (Drug)

Arm 2

Active Comparator

itraconazole oral solution

干预措施: antifungal prophylaxis (Drug)

结局指标

主要结局

Incidence of breakthrough IFD

时间窗: 1 year

次要结局

  • Overall survival(1 year)
  • treatment-related mortality(1 year)

研究者

发起方
Fujian Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ting YANG

Prof.M.D.Ph.D

Fujian Medical University

研究点 (1)

Loading locations...

相似试验